New Gamechanger Vaccine Against Flu Coming Soon

by Bidita Debnath on October 9, 2017 at 10:59 PM
 New Gamechanger Vaccine Against Flu Coming Soon

Influenza viruses cause more than 5 lakh deaths annually. India has been burdened with influenza too. With each passing year, the number of people falling ill and deaths due to flu have been increasing substantially.

The flu burden in India is huge; the total number of cases until October 1 this year had crossed 36,000 countrywide, and the number of deaths was close to 2,000.


Influenza viruses annually affect about a billion people worldwide, and cause 250,000 to 500,000 deaths, mainly in the over-65 age group. Influenza viruses are classified into A, B, C and D types — A and B are known to cause seasonal epidemics; C causes mild respiratory illness, but not an epidemic. Influenza D affects cattle.

A potentially groundbreaking seasonal flu vaccine developed by a team from Oxford University will be tested on around 2,000 humans aged 65 and above living in Berkshire and Oxfordshire in the United Kingdom. The clinical trial, supported by the UK's National Institute for Health Research, will be carried out through Britain's publicly funded national healthcare system, the National Health Service (NHS).

Professor Sarah Gilbert, professor of vaccinology at the university and co-founder of Vaccitech, and her collaborators at the Jenner Institute have put in 10 years of work into the vaccine.

It is believed by the researchers that the new vaccine will provide stronger protection against the flu because of its different mechanism. It could also reduce the severity and duration of flu. The developers feel the vaccine could be a game changer for global health.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Men´s Health News

How Space Travel Impacts Men's Erectile Dysfunction?
Men can have adverse effects on erectile dysfunction due to prolonged space travel and high amounts of galactic cosmic radiation.
Gut Microbiota's Link to Prostate Inflammation in Aging Men
Diagnostic lipid markers for metabolic syndrome and SCFAs correlate with interleukin immunoexpression in benign hyperplasia prostate tissue.
Combination Therapy Holds Promise for Advanced Prostate Cancer Treatment
A combination of decitabine that targets loss of the gene RB1 and DS-7300a that targets the B7-H3 receptors effectively reduces advanced prostate tumor growth.
How Insecticide Exposure Drops Sperm Concentration?
Research reveals a robust association between insecticide exposure and decreased sperm concentration in adult men globally.
Dads' Mental Health Matters for Development of Child
Impact of fathers' mental well-being on child development remains a relatively uncharted territory and is explored by a recent study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Gamechanger Vaccine Against Flu Coming Soon Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests